Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03589859 · ClinicalTrials.gov registry record

Computerized Vestibular Rehabilitation

A clinical trial, sponsored by VA Office of Research and Development.

Completed
Registry status
24
Enrollment target

NCT03589859: Completed study, sponsored by VA Office of Research and Development.

NCT03589859 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03589859 has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
24 participants
Enrollment target

Study Summary

Disorders of vestibular function and balance are an important component of many conditions that commonly affect veterans, such as inner ear diseases, diabetes, and traumatic brain injury. Veterans with vestibular impairment have reduced quality of life, limitations on work and physical activities, and an increased risk of falls. The goal of this research is to develop a more engaging and effective interactive tool for vestibular rehabilitation to improve the lives of affected veterans. The first steps in this process will be to test the ability of the application to facilitate vestibular learning and to test its feasibility in vestibular patients. The hypothesis is that computer-game-based adaptation will induce robust VOR motor learning and will provide an engaging platform for vestibular rehabilitation. Ultimately, our application has the potential to provide more flexible vestibular exercises that will allow therapy to be customized for each patient. It will also have the ability to track a patient's progress over time and to advance exercises as function improves.

Primary Outcome

The vestibulo-ocular reflex gain is the relationship between a rotation of the head and the evoked eye movement. The outcome measure is the ratio of the VOR gain after training to that before training. VOR gain is determined by a scaled fit of eye speed to evoking head speed (normal gain is 1). Note that this experiment was not a treatment of impairment but a test of the ability of the vestibular game to elicit motor learning (away from normal) in individuals with intact motor learning. In that

Interventions

  • DIAGNOSTIC_TEST VOR Test
  • OTHER Computer Game
  • OTHER Nausea Scale

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2018-12-01
Est. Completion 2022-11-30
VA Office of Research and Development

1,668 total trials

What the finished NCT03589859 record still lists

NCT03589859 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.

The record links to 0 conditions, and to 3 interventions - of which VOR Test is the first listed.

NCT03589859 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03589859 about?

NCT03589859 is a clinical study titled "Computerized Vestibular Rehabilitation". Disorders of vestibular function and balance are an important component of many conditions that commonly affect veterans, such as inner ear diseases, diabetes, and traumatic brain injury. Veterans with vestibular impairment have reduced quality of life, limitations on work and physical activities, a...

What is the current status of trial NCT03589859?

This trial is currently completed. The enrollment target is 24 participants. The study started on 2018-12-01. Estimated completion is 2022-11-30.

What interventions are being tested in trial NCT03589859?

The interventions under investigation include: VOR Test (DIAGNOSTIC_TEST), Computer Game (OTHER), Nausea Scale (OTHER).

Who is sponsoring clinical trial NCT03589859?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03589859, the US trial registry maintained by the National Library of Medicine. NCT03589859 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.